3D-QSAR CoMFA and CoMSIA studies on a set of diverse α 1a- adrenergic receptor antagonists

Medicinal Chemistry Research

Volumn 20, Issue 9, 2011, Pages 1455-1464

  Gupta, Amit K ^a   Saxena, Anil K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

3D QSAR; Adrenergic receptors; CoMFA; CoMSIA; Drug design

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS; CONFERENCE PAPER; DRUG ANTAGONISM; HYDROPHOBICITY; STATIC ELECTRICITY; STEREOSPECIFICITY;

EID: 84856217798     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-010-9379-1     Document Type: Conference Paper

References (29)

1. Barbaro R, Betti L, Botta M, Corelli F, Giannaccini G, Maccari L, Manetti F, Strappaghetti G, Corsano S (2001) Synthesis, biological evaluation, and pharmacophore generation of new pyridazinone derivatives with affinity toward a1-and a2-adrenoceptors. J Med Chem 44:2118-2132 (Pubitemid 32861772)
2. Bohm M, Sturzebecher J, Klebe G (1999) Three-dimensional quantitative structure-activity relationship analysis using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin, and factor Xa. J Med Chem 42:458-477 (Pubitemid 29085107)
3. Brasili L, Sorbi C, Franchini S, Manicardi M, Angeli P, Marucci G, Leonardi A, Poggesi E (2003) 1,3-Dioxolane-based ligands as a novel class of 1-adrenoceptor antagonists. J Med Chem 46:1504-1511 (Pubitemid 36512713)
4. Bush BL, Nachbar RB (1993) Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA. J Comput Aided Mol Des 7:587-619
5. Cramer RD III, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA): Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959-5967
6. Debnath B, Samanta S, Naskar SK, Roy K, Jha T (2003) QSAR study on the affinity of some arylpiperazines towards the 5-HT1A/a1-adrenergic receptor using the E-state index. Bioorg Med Chem Lett 13:2837-2842 (Pubitemid 37386235)
7. Fang H, Lu J-F, Xia L (2003) Constructing biophore of uroselective a1-adrenoceptor antagonist. J Chin Pharm Sci 12:188-191
8. Franchini S, Tait A, Prandi A, Sorbi C, Gallesi R, Buccioni M, Marucci G, DeStefani C, Cilia A, Brasili L (2009) (2, 2-Diphenyl-[1, 3]oxathiolan-5- ylmethyl)-(3-phenylpropyl)-amine: A potent and selective 5-HT1A receptor agonist. Chem Med Chem 4:196-203
9. Fumagalli L, Bolchi C, Colleoni S, Gobbi M, Moroni B, Pallavicini M, Pedretti A, Villa L, Vistoli G, Valoti E (2005) QSAR study for a novel series of ortho monosubstituted phenoxy analogues of a1-adrenoceptor antagonist WB4101. Bioorg Med Chem 13:2547-2559 (Pubitemid 40341658)
10. Jain KS, Bariwal JB, Kathiravan MK, Phoujdar MS, Sahne RS, Chauhan BS, Shah AK, Yadav MR (2008) Recent advances in selective a1-adrenoreceptor antagonists as antihypertensive Agents. Bioorg Med Chem 16:4759-4800 (Pubitemid 351625861)
11. Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37:4130-4146 (Pubitemid 24379702)
12. Kulig K, Sapa J, Nowaczyk A, Filipek B, Malawska B (2009) Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2- hydroxy-propyl]-3, 3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and α-adrenolytic activity. Eur J Med Chem 44:3994-4003
13. Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F (2004) Synthesis, screening, and molecular modeling of new potent and selective antagonists at the a1d -adrenergic receptor. J Med Chem 47:1900-1918 (Pubitemid 38453910)
14. Li MY, Xia L (2007) Rational design, synthesis, biological evaluation, and structure-activity relationship studies of novel 1-Indanone a1-adrenoceptor antagonists. Chem Biol Drug Des 70:461-464 (Pubitemid 47609966)
15. Li MY, Tsai K-C, Xia L (2005) Pharmacophore identification of a1aadrenoceptor antagonists. Bioorg Med Chem Lett 15:657-664
16. MacDougall IJA, Griffith R (2006) Selective pharmacophore design for a1-adrenoceptor subtypes. J Mol Graph Model 25:146-157 (Pubitemid 44291551)
17. Maciejewska D, Zolek T, Herold F (2006) CoMFA methodology in structure-activity analysis of hexahydro and octahydropyrido[1, 2-c]pyrimidine derivatives based on affinity towards 5-HT1A, 5-HT2A and a1-adrenergic receptors. J Mol Graph Model 25:353-362 (Pubitemid 44585229)
18. Nowaczyk A, Kulig K, Malawska B (2009) 1-(3-(4-Arylpiperazin-1-yl)- propyl)-pyrrolidin-2-one derivatives as a1-adrenoceptor antagonists: A QSAR study. QSAR Comb Sci 28:979-988
19. Pallavicini M, Fumagalli L, Gobbi M, Bolchi C, Colleoni S, Moroni B, Pedretti A, Rusconi C, Vistoli G, Valoti E (2006) QSAR study for a novel series of ortho disubstituted phenoxy analogues of a1-adrenoceptor antagonist WB4101. Eur J Med Chem 41:1025-1040 (Pubitemid 44353866)
20. Prathipati P, Saxena AK (2003) Comparison of MLR. PLS and GAMLR in QSAR analysis. SAR QSAR Environ Res 14:433-446
21. Quaglia W, Pigini M, Piergentili A, Giannella M, Marucci G, Poggesi E, Leonardi A, Melchiorre C (1999) Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for 1-adrenoreceptor subtypes. J Med Chem 42:2961-2968 (Pubitemid 29370440)
22. Quaglia W, Pigini M, Piergentili A, Giannella M, Gentili F, Marucci G, Carrieri A, Carotti A, Poggesi E, Leonardi A, Melchiorre C (2002) Structure-activity relationships in 1,4-benzodioxanrelated compounds. 7. Selectivity of 4-phenylchroman analogues for a1-adrenoreceptor subtypes. J Med Chem 45:1633-1643 (Pubitemid 34293528)
23. Quaglia W, Santoni G, Pigini M, Piergentili A, Gentili F, Buccioni M, Mosca M, Lucciarini R, Amantini C, Nabissi MI, Ballarin PI, Poggesi E, Leonardi A, Giannella M (2005) Structure-activity relationships in 1,4-benzodioxan- related compounds.8.1{2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6- dimethoxyphenoxy) ethyl]amine clopenphendioxan) as a tool to highlight the involvement of 1d-and 1b-adrenoreceptor subtypes in the regulation of human pγ-3 prostate cancer cell apoptosis and proliferation. J Med Chem 48:7750-7763 (Pubitemid 41698814)
24. Quaglia W, Piergentili A, Bello FD, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A (2008) Structure activity relationships in 1,4-benzodioxan-related compounds. 9. (1) From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel a1Dadrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. J Med Chem 51:6359-6370
25. Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP (2003) New pyrimido[5,4-b]indoles as ligands for a1-adrenoceptor subtypes. J Med Chem 46:2877-2894 (Pubitemid 36775914)
26. Rosini M, Antonello A, Cavalli A, Bolognesi ML, Minarini A, Marucci G, Poggesi E, Leonardi A, Melchiorre C (2003) Prazosin-related compounds: Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for a1-adrenoreceptors. J Med Chem 46:4895-4903 (Pubitemid 37352029)
27. Roy KK, Dixit A, Saxena AK (2008) An investigation of structurally diverse carbamates for acetylcholinesterase (AChE) inhibition using 3D-QSAR analysis. J Mol Graph Model 27:197-208
28. Shakya N, Fatima Z, Saxena AK (2004) 3D-QSAR studies on substituted dihydropyridines for their a1a-adrenergic receptor binding affinity. Med Chem Res 13:812-823 (Pubitemid 41025600)
29. Sorbi C, Franchini S, Tait A, Prandi A, Gallesi R, Angeli P, Marucci G, Pirona L, Poggesi E, Brasili L (2009) 1,3-Dioxolane-based ligands as rigid analogues of naftopidil: Structure-affinity/ activity relationships at a1 and 5-ht1a receptors. Chem Med Chem 4:393-399